Esquire Financial director Coelho sells 11,600 shares

Q: How many ESQ shares did director Anthony Coelho sell, and at what price?

Anthony Coelho sold 11,600 shares of common stock at $126.9987 per share on October 29, 2026. No Rule 10b5-1 plan is reported.

Q: What ESQ shares did Anthony Coelho report holding after the sale?

After the sale, Coelho reported 55,765 shares held directly, 12,910 shares held by trust, and 36,000 shares held by IRA.

Reported post-sale positions include directly held shares as well as shares held through a trust and an IRA.

Available on EDGAR 11/02/2026 - 04:10 PM EST Accepted by SEC EDGAR 11/02/2026 - 04:10 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. director Anthony Coelho sold 11,600 shares of common stock on October 29, 2026, at $126.9987 per share. He reported 55,765 shares held directly after the sale, plus 12,910 shares held by trust and 36,000 shares held by IRA. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 11,600 shares

Net Sell 1 txn

Insider Coelho Anthony

Role Director

Sold 11,600 shs ($1.47M)

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2, F3, F4, F5, F6}	11,600	$126.9987	$1.47M
Holding	Common Stock	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 55,765 shares (Direct); Common Stock — 12,910 shares (Indirect, By Trust); Common Stock — 36,000 shares (Indirect, By IRA)

Footnotes (6)

F1. Includes shares of restricted stock which vest 100% on December 10, 2026.
F2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
F3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
F4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
F5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.
F6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

Key Figures

Common shares sold: 11,600 shares Sale price per share: $126.9987 per share Direct shares after sale: 55,765 shares +2 more

5 metrics

Common shares sold 11,600 shares October 29, 2026

Sale price per share $126.9987 per share October 29, 2026

Direct shares after sale 55,765 shares Reported after the October 29, 2026 sale

Shares held by trust 12,910 shares Reported October 29, 2026

Shares held by IRA 36,000 shares Reported October 29, 2026

Key Terms

restricted stock, three equal annual installments, Rule 10b5-1 plan

3 terms

restricted stock financial

"Includes shares of restricted stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

three equal annual installments financial

"vest in three equal annual installments"

Rule 10b5-1 plan financial

"No Rule 10b5-1 plan is reported"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ESQ shares did director Anthony Coelho sell, and at what price?

Anthony Coelho sold 11,600 shares of common stock at $126.9987 per share on October 29, 2026. No Rule 10b5-1 plan is reported.

What ESQ shares did Anthony Coelho report holding after the sale?

After the sale, Coelho reported 55,765 shares held directly, 12,910 shares held by trust, and 36,000 shares held by IRA.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coelho Anthony

(Last)

(First)

(Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO

NEW YORK

11753

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/29/2026		S		11,600	D	$126.9987	55,765⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾⁽⁵⁾⁽⁶⁾	D
Common Stock								12,910	I	By Trust
Common Stock								36,000	I	By IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Includes shares of restricted stock which vest 100% on December 10, 2026.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 3, 2027.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

	/s/ Eric S. Bader, pursuant to power of attorney	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR